Continuous Renal Replacement Therapy for Pheochromocytoma Crisis With Multiple Organ Failure

被引:8
作者
Seo, Masahiro [1 ]
Yamada, Takahisa [1 ]
Ozu, Kentaro [1 ]
Fukunami, Masatake [1 ]
机构
[1] Osaka Gen Med Ctr, Div Cardiol, Osaka 5588558, Japan
关键词
Pheochromocytoma crisis; Multiple organ failure; Renal replacement therapy; Catecholamine cardiomyopathy;
D O I
10.1097/MAJ.0000000000000433
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pheochromocytoma crisis is a feared and potentially lethal complication associated with excess release of catecholamine from the tumor, which might lead to multiple organ failure (MOF). The definitive treatment for pheochromocytoma is surgical resection. To safely proceed with surgery, hemodynamic stabilization in the acute phase is indispensable, but it might be extremely challenging in case of pheochromocytoma crisis with MOF even if the sufficient pharmacological drugs would be administered. Catecholamine is a dialyzable substance and is removed by renal replacement therapy. In this report, we described 2 cases of pheochromocytoma crisis with MOF, in which we succeeded in controlling acute unstable hemodynamics by means of catecholamine removal with continuous renal replacement therapy. These cases suggest that continuous renal replacement therapy may be effective to manage unstable hemodynamics because of massive catecholamine excretion in patients with pheochromocytoma crisis and MOF.
引用
收藏
页码:508 / 511
页数:4
相关论文
共 7 条
  • [1] Pheochromocytoma: Current approaches and future directions
    Adler, Joel T.
    Meyer-Rochow, Goswin Y.
    Chen, Herbert
    Benn, Diana E.
    Robinson, Bruce G.
    Sippel, Rebecca S.
    Sidhu, Stan B.
    [J]. ONCOLOGIST, 2008, 13 (07) : 779 - 793
  • [2] PLASMA-FREE, SULFO-CONJUGATED AND GLUCURO-CONJUGATED CATECHOLAMINES IN UREMIC PATIENTS
    CUCHE, JL
    PRINSEAU, J
    SELZ, F
    RUGET, G
    BAGLIN, A
    [J]. KIDNEY INTERNATIONAL, 1986, 30 (04) : 566 - 572
  • [3] Heidbreder E, 1986, Contrib Nephrol, V50, P14
  • [4] Pheochromocytoma revealed by acute heart failure. When should we operate? Presented at the ESES Congress, Gothenburg May 25-26, 2012
    Mueller, G.
    Saint, F.
    Hamy, A.
    Lifante, J. C.
    Carnaille, B.
    Sebag, F.
    Menegaux, F.
    Vandwalle, J.
    Drui, D.
    Caillard, C.
    Rodien, P.
    Roy, M.
    Peix, J. L.
    Pattou, F.
    Brunaud, L.
    Henry, J. F.
    Mirallie, E.
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2013, 398 (05) : 729 - 733
  • [5] PHEOCHROMOCYTOMA CRISIS
    NEWELL, K
    PRINZ, RA
    BRAITHWAITE, S
    BROOKS, M
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1988, 1 (03) : S189 - S191
  • [6] Pheochromocytoma Crisis Is Not a Surgical Emergency
    Scholten, Anouk
    Cisco, Robin M.
    Vriens, Menno R.
    Cohen, Jenny K.
    Mitmaker, Elliot J.
    Liu, Chienying
    Tyrrell, J. Blake
    Shen, Wen T.
    Duh, Quan-Yang
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (02) : 581 - 591
  • [7] INFLUENCE OF ULTRAFILTRATION ON PLASMA-RENIN ACTIVITY AND ADRENERGIC SYSTEM
    ZUCCHELLI, P
    CATIZONE, L
    DEGLIESPOSTI, E
    FUSAROLI, M
    LIGABUE, A
    ZUCCALA, A
    [J]. NEPHRON, 1978, 21 (06): : 317 - 324